Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 181

Results For "ET"

10720 News Found

Datar Cancer Genetics signs US $ 250 million contract with Artemis DNA
News | May 09, 2022

Datar Cancer Genetics signs US $ 250 million contract with Artemis DNA

Under the 5-year exclusive agreement, Artemis DNA will provide Datar's pioneering cancer detection Liquid Biopsies in the USA and Vietnam markets


Roche Diabetes Care launches ACCU-FINE pen needles for virtually painless insulin delivery
Biotech | May 09, 2022

Roche Diabetes Care launches ACCU-FINE pen needles for virtually painless insulin delivery

Aims to increase compliance and improve outcomes for People with Diabetes (PwD)


Challenges of Thalassemia management in India bring like-minded stakeholders together
Public Health | May 08, 2022

Challenges of Thalassemia management in India bring like-minded stakeholders together

Ahead of International Thalassemia Day on 8th May, medical professionals and representatives of patient bodies participated in a virtual discussion on the current situation of Thalassemia management in India


Oncocyte completes validation of Therasure transplant monitor test
Biotech | May 08, 2022

Oncocyte completes validation of Therasure transplant monitor test

Digital PCR format allows for rapid turnaround time to facilitate fast and accurate post-transplant treatment decisions


SKS Hospital, Salem installs Carestream’s detector for paediatric studies
Hospitals | May 07, 2022

SKS Hospital, Salem installs Carestream’s detector for paediatric studies

This newly designed small-format detector is made up of caesium iodide technology and is extremely high in resolution, capable of capturing the fine detail of smaller anatomical structures present in paediatric patients


Procter & Gamble Health posts 14 per cent growth in net profit in Q3
Biotech | May 06, 2022

Procter & Gamble Health posts 14 per cent growth in net profit in Q3

The increase in PAT is driven by higher sales and lower marketing and depreciation charge vs the same period last year


USFDA clears Abbott’s test to detect four sexually transmitted infections simultaneously
Drug Approval | May 06, 2022

USFDA clears Abbott’s test to detect four sexually transmitted infections simultaneously

Abbott's multiplex test runs on its most advanced molecular PCR platform, the Alinity m system, which provides fast results in high volumes – detecting four infections simultaneously


Biogen and MedRhythms partner for digital therapeutic targeting the treatment of gait deficits in multiple sclerosis
Biotech | May 06, 2022

Biogen and MedRhythms partner for digital therapeutic targeting the treatment of gait deficits in multiple sclerosis

The investigational prescription digital therapeutic uses a combination of sensors, software, and music based on Rhythmic Auditory Stimulation (RAS)


Zydus receives tentative approval from USFDA for Selexipag tablets
Drug Approval | May 06, 2022

Zydus receives tentative approval from USFDA for Selexipag tablets

The drug will be manufactured at the group's formulation facility at SEZ, Ahmedabad


USFDA permits marketing for new test to improve diagnosis of Alzheimer's disease
News | May 05, 2022

USFDA permits marketing for new test to improve diagnosis of Alzheimer's disease

According to the National Institutes of Health, more than six million Americans, most age 65 or older, may have dementia caused by Alzheimer's disease, a brain disorder known to slowly destroy memory and thinking skills